Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
As of close of business last night, Johnson & Johnson’s stock clocked out at $199.96, down -0.82% from its previous closing price of $201.62. In other words, the price has decreased by -$0.82 from its previous closing price. On the day, 7.36 million shares were traded. JNJ stock price reached its highest trading level at $205.54 during the session, while it also had its lowest trading level at $199.905.
Ratios:
To gain a deeper understanding of JNJ’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 25.95 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 24.58. For the most recent quarter (mrq), Quick Ratio is recorded 0.80 and its Current Ratio is at 1.07. In the meantime, Its Debt-to-Equity ratio is 0.58 whereas as Long-Term Debt/Eq ratio is at 0.50.
Upgrades & Downgrades
In the most recent recommendation for this company, Scotiabank on November 13, 2025, initiated with a Sector Outperform rating and assigned the stock a target price of $230.
On October 20, 2025, Daiwa Securities Upgraded its rating to Outperform which previously was Neutral but kept the price unchanged to $203.
Wells Fargo Upgraded its Equal Weight to Overweight on October 03, 2025, while the target price for the stock was maintained at $212.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 26 ’25 when MORIKIS JOHN G bought 1,250 shares for $206.15 per share. The transaction valued at 257,688 led to the insider holds 1,849 shares of the business.
JOHNSON & JOHNSON sold 6,337 shares of JNJ for $63,560 on Nov 26 ’25. The 10% Owner now owns 4,040,861 shares after completing the transaction at $10.03 per share. On Nov 24 ’25, another insider, JOHNSON & JOHNSON, who serves as the 10% Owner of the company, sold 2,200 shares for $10.06 each. As a result, the insider received 22,132 and left with 4,047,198 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, JNJ now has a Market Capitalization of 481762672640 and an Enterprise Value of 513741946880. As of this moment, Johnson’s Price-to-Earnings (P/E) ratio for their current fiscal year is 19.30, and their Forward P/E ratio for the next fiscal year is 17.35. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.30. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.23 while its Price-to-Book (P/B) ratio in mrq is 6.07. Its current Enterprise Value per Revenue stands at 5.575 whereas that against EBITDA is 16.094.
Stock Price History:
The Beta on a monthly basis for JNJ is 0.34, which has changed by 0.3749318 over the last 52 weeks, in comparison to a change of 0.12529528 over the same period for the S&P500. Over the past 52 weeks, JNJ has reached a high of $207.81, while it has fallen to a 52-week low of $140.68. The 50-Day Moving Average of the stock is 2.91%, while the 200-Day Moving Average is calculated to be 17.17%.
Shares Statistics:
It appears that JNJ traded 8.72M shares on average per day over the past three months and 8729800 shares per day over the past ten days. A total of 2.41B shares are outstanding, with a floating share count of 2.41B. Insiders hold about 0.12% of the company’s shares, while institutions hold 74.47% stake in the company. Shares short for JNJ as of 1763078400 were 20122322 with a Short Ratio of 2.31, compared to 1760486400 on 20626892. Therefore, it implies a Short% of Shares Outstanding of 20122322 and a Short% of Float of 0.84.
Dividends & Splits
With its trailing 12-month dividend rate of 5.08, JNJ has a forward annual dividend rate of 5.14. Against a Trailing Annual Dividend Yield of 0.025195913. The stock’s 5-year Average Dividend Yield is 2.79. The current Payout Ratio is 84.80% for JNJ, which recently paid a dividend on 2025-11-25 with an ex-dividend date of 2025-11-25. Stock splits for the company last occurred on 2001-06-13 when the company split stock in a 2:1 ratio.
Earnings Estimates
Johnson & Johnson (JNJ) is currently under the scrutiny of 18.0 analysts, each contributing to the ongoing evaluation of its stock.The consensus estimate for the next quarter is $2.75, with high estimates of $2.81 and low estimates of $2.65.
Analysts are recommending an EPS of between $10.96 and $10.77 for the fiscal current year, implying an average EPS of $10.86. EPS for the following year is $11.52, with 26.0 analysts recommending between $11.95 and $11.11.
Revenue Estimates
In. The current quarter, 16 analysts expect revenue to total $24.14B. It ranges from a high estimate of $24.48B to a low estimate of $23.88B. As of. The current estimate, Johnson & Johnson’s year-ago sales were $22.52BFor the next quarter, 16 analysts are estimating revenue of $22.99B. There is a high estimate of $23.28B for the next quarter, whereas the lowest estimate is $22.26B.
A total of 22 analysts have provided revenue estimates for JNJ’s current fiscal year. The highest revenue estimate was $94.05B, while the lowest revenue estimate was $93.42B, resulting in an average revenue estimate of $93.75B. In the same quarter a year ago, actual revenue was $88.82BBased on 24 analysts’ estimates, the company’s revenue will be $98.44B in the next fiscal year. The high estimate is $99.64B and the low estimate is $95.16B.
